Skip to content

Evolent Health, Inc. EVH Stock-Based Comp

Stock-Based Comp at other companies

CVS Health logo
CVS HealthCVS
$266M+111%
UnitedHealth Group logo
UnitedHealth GroupUNH
$348M-7.2%
The Oncology Institute, Inc. logo
The Oncology Institute, Inc.TOI
$1.69M+15.6%
Astrana Health logo
Astrana HealthASTH
$9.9M+26.7%
BrightSpring Health Services, Inc. logo
BrightSpring Health Services, Inc.BTSG
$3.68M-76.6%
Elevance Health logo
Elevance HealthELV
$55M-32.1%

Other financials

Income statement

See full
Revenue$496.2M+2.6%
Gross profit$83.8M-18.2%
Operating income-$10.6M-553%
Net income-$26.6M+58.8%
EPS (diluted)-$0.24+61.9%

Balance sheet

See full
Cash & equivalents$142.0M-42.4%
Total debt$985.4M+13.3%
Total equity$396.4M-57.6%
Total assets$1.9B-29.2%

Cash flow

See full
Operating cash flow-$984.0K-122%

Valuation

See full
Market cap$565.78M-47.9%
Enterprise value$1.41B-17.6%
P/S0.3×-0.2×

Profitability

See full
Gross margin20.2%+4.9pp
Operating margin-22.2%-23.5pp
Net margin-26.3%-33.2pp
FCF margin-9.7%

Returns & leverage

See full
Return on equity-74.6%-90.1pp
Debt / equity2.5×+1.6×
Current ratio1.3×+0.3×

Where this comes from

Reported directly by Evolent Health, Inc. in its filing.

Tagged under the XBRL concept us-gaap:ShareBasedCompensation.

The official record: Evolent Health, Inc.’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Evolent Health, Inc.'s stock-based comp.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Evolent Health, Inc.'s stock-based comp?
Evolent Health, Inc. (EVH) reported stock-based comp of $10.65M in Q1 2026.
How has Evolent Health, Inc.'s stock-based comp changed year-over-year?
Evolent Health, Inc.'s stock-based comp decreased by 3.9% year-over-year, from $11.08M to $10.65M.
What is the long-term trend for Evolent Health, Inc.'s stock-based comp?
Over 3 years (2021 to 2025), Evolent Health, Inc.'s stock-based comp has grown at a 33.5% compound annual growth rate (CAGR), from $16.71M to $39.74M.
What does stock-based comp mean?
Total non-cash stock-based compensation expense for equity awards (RSUs, options, ESPP), added back to net income in cash flow reconciliation.